Bioequivalence of Daunorubicin Cytarabine Liposomes in Naive AML Patients
Clinical trial NCT04920500 · UNKNOWN
Trial details
- NCT number
- NCT04920500
- Sponsor
- CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-04
- Primary completion
- 2021-06-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.